Rosanna Coppo

发表

Next-Generation Morphometry for pathomics-data mining in histopathology

Ivan G. Costa, P. Boor, Mingbo Cheng, 2023, Nature Communications.

Tackling stain variability using CycleGAN-based stain augmentation

P. Boor, R. D. Bülow, Nassim Bouteldja, 2022, Journal of pathology informatics.

Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy: Insights from the NEFIGAN trial.

D. Maixnerova, L. Pérez-Alós, C. Seikrit, 2023, Kidney international.

Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy.

S. Bellur, S. Troyanov, Rosanna Coppo, 2024, Kidney international.

Evaluating Progression Risk in Patients With Immunoglobulin A Nephropathy

Rosanna Coppo, D. C. Cattran, Jürgen Floege, 2023, Kidney international reports.

Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy.

V. D’Agati, C. Alpers, B. Julian, 2017, Kidney international.

Microscopic hematuria as a risk factor for IgAN progression: considering this biomarker in selecting and monitoring patients

F. Fervenza, Rosanna Coppo, Ladan Zand, 2023, Clinical kidney journal.

Application of the updated International IgA Nephropathy Prediction Tool in children one- or two-years post-biopsy.

L. Peruzzi, R. Katafuchi, A. Cambier, 2024, Kidney international.

Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis Nephritis

C. Zeng, L. Peruzzi, D. Maixnerova, 2024, Clinical journal of the American Society of Nephrology : CJASN.

IPNA clinical practice recommendations for the diagnosis and management of children with IgA nephropathy and IgA vasculitis nephritis.

H. Trimarchi, M. Mantan, K. Gibson, 2024, Pediatric nephrology.